The Global Irritable Bowel Syndrome Treatment Market Is Witnessing High Growth Owing To the High Incidence of Irritable Bowel Syndrome among Individuals in the World

 


Irritable Bowel Syndrome Treatment 

Irritable Bowel Syndrome Treatment Market, by Drug Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, and Others), by Medical Condition (IBS-constipation and IBS-diarrhea), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030.

Market Overview:

Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder that affects the large intestine (colon). It is a chronic condition that causes symptoms such as constipation, bloating, abdominal pain, diarrhea, and gas. The exact cause of IBS is not known, but it is believed to be a combination of factors such as abnormal intestinal contractions, nerve dysfunction, inflammation, and changes in gut bacteria. IBS is typically diagnosed based on symptoms, and there is no specific test to confirm the diagnosis. However, healthcare professionals may perform tests to rule out other conditions with similar symptoms. Treatment for IBS may involve lifestyle changes such as dietary modifications, stress management, and exercise, as well as medication to relieve symptoms.

Competitive Landscape:

Major players operating in the global Irritable Bowel Syndrome Treatment Market include Takeda Pharmaceutical Company Limited, Ironwood Pharmaceuticals, Inc., GSK plc., Novartis AG, Astellas Pharma Inc., Ardelyx, Bausch Health Companies Inc., Mallinckrodt, Synergy Pharma, and Abbott.

Key Market Drivers:

The rising prevalence of irritable bowel syndrome (IBS) among the population worldwide is the major driver of the global irritable bowel syndrome treatment market. For instance, according to the National Institutes of Health (NIH), around 11% of the global population is living with irritable bowel syndrome. Moreover, the growing geriatric population, changing lifestyles, and increasing awareness about the disease are the other factors contributing to market growth. The increase in research and development activities by pharmaceutical companies to develop more effective treatment options for IBS is also boosting the growth of the global irritable bowel syndrome treatment market.

Covid-19 Impact Analysis:

During the COVID-19 pandemic, there have been several developments in the global Irritable Bowel Syndrome Treatment Market. For instance, in June 2022, Ferring B.V. and I-MAB Biopharma Co., Ltd. partnered in order to develop advanced treatment options for inflammatory bowel disease (IBD), along with other inflammatory conditions.

Key Takeaways:

·       North America is expected to dominate the global irritable bowel syndrome treatment market due to the high prevalence of the disease in the region. The increasing awareness about the disease and the availability of advanced healthcare infrastructure are the other factors contributing to market growth in the region. For instance, in April 2022, Ardelyx introduced the first and only NHE3 inhibitor called IBSRELA for treating irritable bowel syndrome in adults.

·       The Asia Pacific region is expected to witness the highest growth rate due to the increasing population and rising prevalence of IBS in the region. Moreover, the high rate of developments by key companies in the region is estimated to enhance the growth of the global irritable bowel syndrome treatment market.  For instance, in March 2022, Indegene collaborated with metaMe Health, for introducing a prescription digital therapeutic called Regulora in the market, in order to treat abdominal pain resulting from Irritable Bowel Syndrome.

Comments

Post a Comment

Popular posts from this blog

Forging has significant application in creation of various metal for wide range of applications

Image
Forging refers to any process that produces metal from scratch by subjecting it to an external force. Metal forgers can be persons or machines. This techniques may involve grinding (for example, to produce alloyed steel) or may involve the application of pressure to apply heat to the metal piece until it is malleable. The actual process depends on various factors, including the material being forged, its shape, and the degree of stress that is placed on it. Forged grain is the product of Forging with grains of metals pushed against each other through a forge-like tool and into the cladding that forms the final shape of the metal after it has been done. It is the principal production process in most metals. It uses local or repetitive thrusts delivered by a hammer or die to apply mechanical blows to the metal piece until it becomes malleable. It is frequently classified according to the speed at which it's done: fast, cold, or hot. There are many types of forgers available today...
Read more

Ginseng Market Outlook, Analysis and forecast up to 2028

Image
  Ginseng Market Ginseng is a slow-growing perennial plant with green oval-shaped leaves and meaty roots that can persist for more than a century. Ginseng is classified into two types: American ginseng and Asian ginseng. Panax quinquefolius is the scientific name for American ginseng, whereas Panax ginseng is the scientific name for Asian ginseng. Ginseng is widely used as a herb to increase the body's energy levels. Ginseng's antioxidant and anti-inflammatory qualities serve to enhance the immune system, lowering the risk of viral and microbial infections. Ginseng also helps to lower the risk of diseases such as lung cancer, skin cancer, and liver cancer. Other health advantages of ginseng include lower blood sugar levels and improved cognitive functions such as memory and conduct. Ginseng is mostly grown in the United States, Canada, and South Korea. Ginseng has been used as a herbal medicine in China for generations, and the country is one of its largest users. Asia Pacifi...
Read more

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19

Image
Germany Vaccine Contract Manufacturing industry is expected to witness significant growth in the near future, due to emergence of Covid-19. In Germany, from 3 January 2020 to 4:06pm CEST, 18 August 2021, there have been 3,835,375 confirmed cases of COVID-19 with 91,921 deaths, reported to WHO. As of 15 August 2021, a total of 97,884,043 vaccine doses have been administered. The increasing demand for safe and cost-effective vaccines due to unmatchable quality, consistent delivery, and unparalleled security, have contributed to the increasing growth and scope of this industry. The increasing demand for vaccines and resulting profit potential have led to significant growth in the number of contract manufacturing plants located across the world. A major focus of such plants is developing cost effective, high quality vaccines that could be made available to public health organizations and other medical organizations. Several new and innovative technologies are also being developed to man...
Read more